Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Borrelia afzelii causes a skin condition in France, a gene is linked to hair loss in Caucasian women, and various genetic mutations affect skin diseases.

Topical treatments can deliver active molecules to skin stem cells, potentially helping treat skin and hair disorders, including skin cancers and hair loss.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Polymeric nanoparticles show promise for treating skin diseases.

Niosomes are a promising, stable, and cost-effective drug delivery system with potential for improved targeting and safety.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Artificial skin development has challenges, but new materials and understanding cell behavior could improve tissue repair. Also, certain growth factors and hydrogel technology show promise for advanced skin replacement therapies.

Hair follicles may soon be used more for targeted and systemic drug delivery.

Probiotic bacteria improved skin and hair health in aged mice.

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

The sebaceous gland has more roles than just producing sebum and contributing to acne, and new research could lead to better skin disease treatments.

Future acne treatments should aggressively target inflammation to prevent scarring.

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Mutations in the hairless gene in mice affect its expression and lead to a range of developmental issues in multiple tissues.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Gene therapy has potential as a future treatment for Hutchinson-Gilford progeria syndrome.

Male rats have more somatostatin neurons than females due to testosterone converting to estrogen during early development.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

Lipid–polymer hybrid nanoparticles can improve genome editing delivery and outcomes.

New treatments for epidermolysis bullosa show promise in improving patients' lives, but a cure is still not available.

Melatonin receptors in hair follicles help regulate hair growth and could treat hair loss.

Zebrafish larvae are used to study and find treatments for ear cell damage because they are easier to observe and test than mammals.

Silver nanoparticles are useful in medicine and technology for their antibacterial properties and potential in drug delivery and dentistry.

New treatments for hair loss are being developed using molecular biology.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.